In the last trading session, 1.71 million Biodesix Inc (NASDAQ:BDSX) shares changed hands as the company’s beta touched 0.94. With the company’s per share price at $0.28 changed hands at $0.03 or 12.74% during last session, the market valuation stood at $41.35M. BDSX’s last price was a discount, traded about -628.57% off its 52-week high of $2.04. The share price had its 52-week low at $0.17, which suggests the last value was 39.29% up since then. When we look at Biodesix Inc’s average trading volume, we note the 10-day average is 1.19 million shares, with the 3-month average coming to 8.75 million.
Analysts gave the Biodesix Inc (BDSX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.33. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended BDSX as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Biodesix Inc (NASDAQ:BDSX) trade information
Instantly BDSX was in green as seen at the end of in last trading. With action 5.02%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -81.19%, with the 5-day performance at 5.02% in the green. However, in the 30-day time frame, Biodesix Inc (NASDAQ:BDSX) is -13.30% down. Looking at the short shares, we see there were 5.26 million shares sold at short interest cover period of 0.23 days.
The consensus price target for the stock as assigned by Wall Street analysts is 3, meaning bulls need an upside of 90.67% from its current market value. According to analyst projections, BDSX’s forecast low is 3 with 3 as the target high. To hit the forecast high, the stock’s price needs a -971.43% plunge from its current level, while the stock would need to soar -971.43% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 69.26%. The 2025 estimates are for Biodesix Inc earnings to increase by 26.46%, but the outlook for the next 5-year period is at 33.97% per year.
BDSX Dividends
Biodesix Inc is expected to release its next quarterly earnings report on 2025-May-13.
Biodesix Inc (NASDAQ:BDSX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 52.11% of Biodesix Inc shares while 36.46% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 76.13%. There are 36.46% institutions holding the Biodesix Inc stock share, with TELEMARK ASSET MANAGEMENT, LLC the top institutional holder. As of 2024-06-30, the company held 6.513% of the shares, roughly 8.28 million BDSX shares worth $12.67 million.
SOLEUS CAPITAL MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 4.8062% or 6.11 million shares worth $9.35 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 2.3 shares estimated at $0.65 million under it, the former controlled 1.57% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.97% of the shares, roughly 1.42 shares worth around $0.4 million.
